NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Inspiren

Inspiren

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.inspiren.com/

Last Round

Series B

Sep 25, 2025

Total Funding Raised

$144.65M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Inspiren is a healthcare technology company that provides an AI-powered ecosystem for the senior living industry to integrate care planning, resident safety, workforce optimization, and emergency response.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Healthcare Analytics, Workflow Automation

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

clinical workflow automationpatient safety monitoringhealth IoTcomputer visionhand hygiene complianceedge AIsmart hospitalhealthcare analyticsfall detectionclinical quality improvementmedical deviceSaaSAI-native healthcaredigital healthambient sensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Inspiren Comparables

Compare Inspiren with similar companies based on industry and business-model similarity.

Inspiren comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Artisight
88%
VirtuSense Technologies
80%
AvaSure
80%

Inspiren Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BSep 25, 2025
Series AMar 20, 2025
SeedAug 7, 2023

Key People

Founding team and executive leadership

Dominique Simoneau-Ritchie

Chief Technology Officer

Executive Team

Gabrielle Fernandes

Chief Financial Officer

Executive Team

Mike Hsu

Chief Operating Officer

Executive Team

Michael Wang

Chief Clinical Officer

Executive Team

Inspiren Investors

Notable investors and investment history

Inspiren investors
InvestorRounds
Third PrimeSeries B, Series A
Story VenturesSeries B, Series A
Scale Venture PartnersSeries B
Avenir Growth CapitalSeries B, Series A
Studio VCSeries B, Series A
Insight PartnersSeries B
Primary Venture PartnersSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Open roles increased to 130, 73% of headcount.

  • Jul 13, 2026

    Open roles increased to 89, representing 50% of headcount.

Inspiren Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Inspiren Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Inspiren's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range177
Year Founded2016
Last FundingSep 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.